Valtanen H - Search Results

1

Steps toward mapping the human vasculature by phage display.

Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardó-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R. Arap W, et al. Among authors: valtanen h. Nat Med. 2002 Feb;8(2):121-7. doi: 10.1038/nm0202-121. Nat Med. 2002. PMID: 11821895

2

Tumor targeting with a selective gelatinase inhibitor.

Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkilä P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R. Koivunen E, et al. Among authors: valtanen h. Nat Biotechnol. 1999 Aug;17(8):768-74. doi: 10.1038/11703. Nat Biotechnol. 1999. PMID: 10429241

3

Use of intein-directed peptide biosynthesis to improve serum stability and bioactivity of a gelatinase inhibitory peptide.

Björklund M, Valtanen H, Savilahti H, Koivunen E. Björklund M, et al. Among authors: valtanen h. Comb Chem High Throughput Screen. 2003 Feb;6(1):29-35. doi: 10.2174/1386207033329869. Comb Chem High Throughput Screen. 2003. PMID: 12570750

4

Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide.

Medina OP, Kairemo K, Valtanen H, Kangasniemi A, Kaukinen S, Ahonen I, Permi P, Annila A, Sneck M, Holopainen JM, Karonen SL, Kinnunen PK, Koivunen E. Medina OP, et al. Among authors: valtanen h. Anticancer Res. 2005 Jan-Feb;25(1A):33-42. Anticancer Res. 2005. PMID: 15816516 Free article.

5

Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

Lehti K, Lohi J, Valtanen H, Keski-Oja J. Lehti K, et al. Among authors: valtanen h. Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):345-53. doi: 10.1042/bj3340345. Biochem J. 1998. PMID: 9716492 Free PMC article.

6

Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain.

Lehti K, Valtanen H, Wickström SA, Lohi J, Keski-Oja J. Lehti K, et al. Among authors: valtanen h. J Biol Chem. 2000 May 19;275(20):15006-13. doi: 10.1074/jbc.M910220199. J Biol Chem. 2000. PMID: 10748199 Free article.

7

Expression and purification of soluble and inactive mutant forms of membrane type 1 matrix metalloproteinase.

Valtanen H, Lehti K, Lohi J, Keski-Oja J. Valtanen H, et al. Protein Expr Purif. 2000 Jun;19(1):66-73. doi: 10.1006/prep.2000.1216. Protein Expr Purif. 2000. PMID: 10833392

8

Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene.

Lohi J, Lehti K, Valtanen H, Parks WC, Keski-Oja J. Lohi J, et al. Among authors: valtanen h. Gene. 2000 Jan 25;242(1-2):75-86. doi: 10.1016/s0378-1119(99)00549-1. Gene. 2000. PMID: 10721699

9

Liposomal Tumor Targeting in Drug Delivery Utilizing MMP-2- and MMP-9-Binding Ligands.

Penate Medina O, Haikola M, Tahtinen M, Simpura I, Kaukinen S, Valtanen H, Zhu Y, Kuosmanen S, Cao W, Reunanen J, Nurminen T, Saris PE, Smith-Jones P, Bradbury M, Larson S, Kairemo K. Penate Medina O, et al. Among authors: valtanen h. J Drug Deliv. 2011;2011:160515. doi: 10.1155/2011/160515. Epub 2010 Dec 29. J Drug Deliv. 2011. PMID: 21490745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters